DiaSorin S.p.A. (DSRLF) Comparison with companies in other sectors?

DiaSorin S.p.A. has a share price of 53.94M. You can analyze DiaSorin S.p.A. (DSRLF) competitors across different market sectors through stock heatmaps.

What are DSRLF's NET and operating margins?

DiaSorin S.p.A. (DSRLF) operating margin is around 0.39, and net profit margin is approximately 0.16 as of the latest reports.

In what way does DSRLF's earnings per share (EPS) trend reflect its financial momentum?

DiaSorin S.p.A. (DSRLF) EPS is 4.04 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for DiaSorin S.p.A. is 26.90, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for DiaSorin S.p.A.?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for DiaSorin S.p.A. like P/E which is 25.98, P/B which is 2.99, and PEG which is 10.59. Compare them with sector averages to evaluate if the stock is priced fairly.

DiaSorin S.p.A.

DSRLF•PNK

Healthcare

Medical - Diagnostics & Research

$107.68

$0.00(0.00%)

DiaSorin S.p.A. (DSRLF) Fundamental Analysis: Financial Health, Valuation, and Key Ratios

Dive into Apple Inc.’s fundamentals including valuation ratios, profitability, efficiency metrics, and financial health. Use this data to assess long-term investment quality and compare it with sector benchmarks.

EPS (TTM)

$4.04

P/E Ratio

26.90

ROE

0.12%

Net Margin

0.16%

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$5.86B

Shares OutstandingTotal number of shares issued

$53.94M

Book Value/ShareNet worth per share

$31.25

Revenue/ShareAnnual revenue per share

$22.45

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$4.04

Net MarginNet income as percentage of revenue

16.05%

Operating MarginOperating income as percentage of revenue

38.54%

ROEReturn on shareholders' equity

11.57%

ROAReturn on total assets

7.43%

ROCEReturn on capital employed

17.85%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

$4.40

Cash/ShareCash and equivalents per share

FCF YieldFree cash flow as percentage of market cap

4.70%

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

$1.20

Dividend YieldAnnual dividend as percentage of stock price

1.28%

Financial Ratios Analysis data is not available for DSRLFFinancial Ratios Analysis details for DSRLF are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for DSRLFSector Benchmarking details for DSRLF are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for DiaSorin S.p.A. Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of DiaSorin S.p.A.. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account DiaSorin S.p.A.'s unique business strengths and challenges.

Key Financial Metrics for DiaSorin S.p.A.

For DiaSorin S.p.A., essential financial indicators include EPS 4.04, PE 26.90, and ROE 0.12. These key ratios reveal insights into DiaSorin S.p.A.'s profitability, valuation, and operational health. Understanding these metrics enables you to compare DiaSorin S.p.A. with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of DiaSorin S.p.A.

Metrics like Net Margin 16.05% and ROA 7.43% shed light on how well DiaSorin S.p.A. is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether DiaSorin S.p.A. can sustain its operations and continue growing in the future.

Valuation and Market Position of DiaSorin S.p.A.

Using ratios such as P/B Ratio 2.99 and PEG Ratio 10.59, investors can assess whether DiaSorin S.p.A. is appropriately valued based on its financials and growth potential. These figures, combined with DiaSorin S.p.A.'s market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for DiaSorin S.p.A.

Financial health indicators, such as Debt/Equity Ratio 0.40 and Cash Flow $4.40, provide a snapshot of DiaSorin S.p.A.'s ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like DiaSorin S.p.A., is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for DiaSorin S.p.A.

Investing in DiaSorin S.p.A. based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at DiaSorin S.p.A. focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;